Watch the webinar recording
At the end of this learning activity the participant should be able to:
- Apply a systematic approach to the detection of abnormal glucose metabolism, including diabetes and prediabetes, in patients presenting with coronary artery disease
- Identify patients with diabetes and stable coronary artery disease who may benefit from revascularisation
- Contrast the impact and role of PCI and CABG in patients with diabetes and stable coronary artery disease
- Recognise the importance of Heart Team discussion following diagnostic angiography and before revascularisation for patients with diabetes and stable multivessel disease
- Formulate a plan for patients with diabetes and coronary disease undergoing revascularisation for optimal medical management, preparation and follow-up
The Heart Team
Dr Peter Kearney
Consultant General, Interventional Cardiologist and Chair of the Cardiovascular Division at Cork University Hospital (Ireland)
Dr Dimitrios Richter
Head of Cardiac Dept, Euroclinic, Athens (Greece)
Professor Stephan Windecker
Head of interventional cardiology at the Swiss Cardiovascular Cluster Bern
University Hospital, Bern (Switzerland)
Professor Ronan Roussel
Hospital Bichat Claude Bernard, Paris (France)
Professor Philippe Kolh (EACTS representative)
Cardiovascular surgeon, Professor of Physiology and Biochemistry ; University of Liège
Chief Information Officer (CIO); Chairman of the Department of Medico-Economic Information at the University Hospital of Liège (Belgium)
The online programme includes 2 clinical cases, online assessment and interactive discussions with the Heart Team who will give you some useful tips for your daily clinical practice.
You will be able to interact live during the webinar by sending your questions by chat. Our key opinion leaders will provide feedback live.
This programme is supported by Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb and Pfizer Alliance, Daiichi Sankyo Europe GmbH, Novartis Pharma AG and SERVIER in the form of unrestricted educational grants. The scientific programme has not been influenced in any way by its sponsors.